Pharmaceutical Technology

SEPTEMBER 23, 2022

If both of these therapies go on to win FDA approvals, Novaliq and Bausch + Lomb will likely be in a strong position to compete against the current market players. TRPM8 receptors are associated with the detection of ocular surface dryness and are activated by evaporative cooling and hyperosmolarity, which can lead to tear production.

Development 147

Development Drugs Clinical Trials Clinical Trials 147

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Companies can save valuable time and resources as well by taking advantage of the FDA’s 505(b)(2) approval pathway. More FDC products flowing into pharma pipelines.

Manufacturing 130

Manufacturing Production Packaging Packaging 130

XTalks

JUNE 14, 2023

Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. One such approved medication is Miebo , an ophthalmic solution developed by Bausch + Lomb and Novaliq.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

XTalks

SEPTEMBER 19, 2024

It was engineered to have high potency, bioavailability and kinase selectivity that led to improved efficacy and safety in B-cell malignancies. Zanubrutinib has five US Food and Drug Administration (FDA)-approved indications and the broadest label in its class.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52